Elecsys® CA 15-3 II
The Elecsys CA 15-3 II is a diagnostic test offered by Roche Diagnostics. It is used for the quantitative measurement of CA 15-3 in human serum or plasma. CA 15-3 is a protein that is produced by certain types of cancer cells, and its levels can be elevated in various cancer conditions.
The Elecsys CA 15-3 II test utilizes an electrochemiluminescence immunoassay (ECLIA) technology. It is performed on Elecsys immunoassay analyzers, which are automated systems used in clinical laboratories.
Description
Immunological in vitro assay for quantitative determination of CA 15‑3 in human serum and plasma to aid in the management of breast cancer patients. In conjunction with other clinical and diagnostic procedures, serial testing with this assay is an aid
- in the early detection of recurrence in previously treated stage II and III breast cancer patients
- for monitoring response to therapy in metastatic breast cancer patients
The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers.
Reviews
There are no reviews yet.